remdesivir (Q28209496)
Jump to navigation
Jump to search
chemical compound and antiviral drug
- GS-5734
- 2-ethylbutyl (2S)-2-({[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl}amino)propanoate
- Veklury
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | remdesivir |
chemical compound and antiviral drug |
|
Statements
C₂₇H₃₅N₆O₈P
0 references
Nc3ncnn2c3ccc2C(C#N)(C1O)OC(C1O)CO[P](=O)(NC(C)C(=O)OCC(CC)CC)Oc4ccccc4
0 references
CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4
0 references
1 reference
22 January 2022
The antiviral remdesivir should not be used as treatment for hospitalized Covid-19 patients, the World Health Organization said Thursday, only a month after the Food and Drug Administration approved the drug to treat patients over age 12 who are hospitalized with Covid-19. (English)
1 reference
22 January 2022
Although remdesivir performed well in preclinical studies, it did not meet efficacy endpoints in a randomized trial conducted during an Ebola outbreak. (English)
1 reference
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
2 references
22 January 2022
WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients. (English)
22 January 2022
However, the clinical efficacy of remdesivir for COVID-19 remains contentious, as several trials have not found statistically significant differences in either time to clinical improvement or mortality between remdesivir-treated and control groups. (English)
1 reference
22 January 2022
Although remdesivir performed well in preclinical studies, it did not meet efficacy endpoints in a randomized trial conducted during an Ebola outbreak. (English)
Remdesivir
0 references
Identifiers
2 references
EMEA/H/C/005622
0 references
1 reference
1 reference
Investigational Drugs in RxNorm (English)
2 April 2020
Sitelinks
Wikipedia(50 entries)
- arwiki ريمديسيفير
- bnwiki রেমডেসিভির
- cawiki Remdesivir
- cswiki Remdesivir
- dawiki Remdesivir
- dewiki Remdesivir
- elwiki Ρεμντεσιβίρη
- enwiki Remdesivir
- eswiki Remdesivir
- euwiki Remdesivir
- fawiki رمدسیویر
- fiwiki Remdesiviiri
- frwiki Remdésivir
- hewiki רמדסיביר
- hiwiki रेमडेसिविर
- hrwiki Remdesivir
- huwiki Remdezivir
- hywiki Ռեմդեսիվիր
- idwiki Remdesivir
- iswiki Remdesivir
- itwiki Remdesivir
- jawiki レムデシビル
- kawiki რემდესივირი
- kowiki 렘데시비르
- ltwiki Remdesiviras
- mlwiki റെംഡെസിവിർ
- mswiki Remdesivir
- mywiki Remdesivir
- nlwiki Remdesivir
- nowiki Remdesivir
- orwiki ରେମଡେସିଭିର
- plwiki Remdesiwir
- pnbwiki ریمڈیسیویر
- ptwiki Remdesivir
- rowiki Remdesivir
- ruwiki Ремдесивир
- simplewiki Remdesivir
- sqwiki Remdesivir
- srwiki Remdesivir
- svwiki Remdesivir
- tawiki ரெம்டிசிவியர்
- trwiki Remdesivir
- ugwiki رېمدېسىۋىر(ۋاكسىن)
- ukwiki Ремдесивір
- urwiki ریمڈیسیویر
- viwiki Remdesivir
- wuuwiki 瑞德西韦
- xmfwiki რემდესივირი
- zh_yuewiki 瑞德西韋
- zhwiki 瑞德西韦
Wikibooks(0 entries)
Wikinews(1 entry)
- ruwikinews Категория:Ремдесивир
Wikiquote(0 entries)
Wikisource(0 entries)
Wikiversity(0 entries)
Wikivoyage(0 entries)
Wiktionary(0 entries)
Multilingual sites(1 entry)
- commonswiki Category:Remdesivir